• 29. 5. 2017

    Krka Awards Day

    At a ceremony near the Otočec castle we conferred recognition awards to those employees who celebrated their many years of service, best employees and best managers as well as those who proposed the most useful proposals and improvements.

  • 22. 5. 2017

    Choice for Krka's medicine is choice for a clinically proven medicine

    Extensive clinical experience is one of the key added values of Krka's medicines. It demonstrates that treatment with Krka’s medicines is supported by clinical evidence.

  • 17. 5. 2017

    World Hypertension Day

    World Hypertension Day is celebrated every year on 17 May. This year global awareness campaign May Measurement Month 2017 (MMM 2017) is organised. International Society of Hypertension has an ambitious goal to achieve – screen 25 million people from all around the world who have not had their blood pressure measured during the last year. By doing so they wish to raise awareness of this disease that is the cause of death for 9.6 million people.

  • 11. 5. 2017

    Krka presented its operating results for the first quarter of 2017

    The Krka Group sales in the first quarter of 2017 totalled €321 million, an increase by 7% compared to the same period last year, resulting in €42.7 million of net profit, a 6% year-on-year increase. The Krka Company sold €312.2 million worth of products and services and generated €45.3 million of net profit.

  • 8. 5. 2017

    Synergy in the treatment of cardiovascular diseases

    Prevention of the development of cardiovascular diseases is one of the greatest challenges of health care. Controlling risk factors is key to the prevention of the development of these diseases. Various risk factors often occur together, e.g. more than half of all people with high blood pressure also have high cholesterol. When these two risk factors occur together, their impact on disease progression is not summed but multiplied. Failing to control high blood pressure and cholesterol in practice is worrying.